Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patient

LUND, Sweden, July 17, 2023 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline, interim data...

Related Keywords

Sweden ,Stockholm ,Italy ,Swedish ,Fredrik Tiberg ,Diego Ferone ,University Of Genova ,Business Development Officertel ,Camuru President ,Acromegaly Index ,Patient Satisfaction ,Treatment Satisfaction Questionnaire ,Acromegaly Quality ,Life Questionnaire ,Internal Medicine ,Medical Specialties ,Policlinico San Martino ,Nasdaq Stockholm ,Chief Business Development ,